Economides Vassiliki 4
4 · Kezar Life Sciences, Inc. · Filed Mar 29, 2021
Insider Transaction Report
Form 4
Economides Vassiliki
SVP, Strategy & External Aff.
Transactions
- Purchase
Common Stock
[F1]2019-05-30$10.19/sh+750$7,643→ 11,320 total
Footnotes (1)
- [F1]Total reflects 3,000 shares of common stock acquired on November 15, 2020 through the Company's 2018 Employee Stock Purchase Plan.
Signature
/s/ Marc Belsky, Attorney-in-fact|2021-03-29